Catalytic asymmetric hydrogenation of α- and β-enamido phosphonates was developed using a complex formed in situ through a chiral hybrid phosphine-bicyclic bridgehead phosphoramidite ligand and rhodium metal precursor as the catalyst. This strategy afforded a wide variety of substrates in excellent yield (96-99%) and enantiomeric excess (≤99%) with very low catalyst loading (S/C up to 10 000) and relatively mild reaction conditions. Further investigations suggested that the hydrogenation reaction occurred only at the CC bond of the enamido phosphate stage without tautomerization to the imine form. Tandem hydrolysis reactions of hydrogenated products gave the corresponding α- and β-amino phosphonic acids in fairly high yield, which could be multipurpose building blocks for bioorganic chemistry, medicinal chemistry and organic synthesis.
Rh-catalyzed asymmetric hydrogenation of α- and β-enamido phosphonates: highly enantioselective access to amino phosphonic acids.
Published 2022 in Organic and biomolecular chemistry
ABSTRACT
PUBLICATION RECORD
- Publication year
2022
- Venue
Organic and biomolecular chemistry
- Publication date
2022-11-03
- Fields of study
Medicine, Chemistry
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-39 of 39 references · Page 1 of 1
CITED BY
Showing 1-2 of 2 citing papers · Page 1 of 1